# Carlsmed Inc. (CARL)

Source: https://www.quantisnow.com/company/CARL
Generated: 2026-10-30T16:28:58.479Z

- Ticker: CARL
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2025
- SEC CIK: 0001794546

## Latest CARL news and filings

- 2026-10-27 20:30 UTC [Earnings Date] [Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026](https://www.quantisnow.com/insight/carlsmed-inc-to-report-third-quarter-2026-financial-results-on-6759446)
- 2026-10-14 19:40 UTC [SEC Form 144] [SEC Form 144 filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-carlsmed-inc-6746434)
- 2026-10-14 13:00 UTC [Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System](https://www.quantisnow.com/insight/carlsmed-launches-aprevo-lumbar-bi-lateral-posterior-system-6746119)
- 2026-10-06 20:59 UTC [SEC Form 4] [SEC Form 4 filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-carlsmed-inc-6739268)
- 2026-10-02 20:01 UTC [Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/carlsmed-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-6734216)
- 2026-10-01 21:35 UTC [SEC Form 4] [Chief Operating Officer Bertolini Jeffrey sold $3,400 worth of shares (243 units at $13.99) as part of a pre-agreed trading plan and exercised 243 shares at a strike of $2.23 (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-bertolini-jeffrey-sold-3400-worth-of-shares-6733062)
- 2026-10-01 21:27 UTC [SEC Form S-8] [SEC Form S-8 filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-carlsmed-inc-6733028)
- 2026-10-01 13:00 UTC [Leadership Update] [Carlsmed Appoints Tony Jarc as Chief Product and AI Officer](https://www.quantisnow.com/insight/carlsmed-appoints-tony-jarc-as-chief-product-and-ai-officer-6731708)
- 2026-09-30 23:51 UTC [SEC Form 3] [New insider Kamocsay Jennifer claimed ownership of 56,222 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-kamocsay-jennifer-claimed-ownership-of-56222-shares-sec-6731092)
- 2026-09-30 23:37 UTC [SEC Form 4] [CFO, Treasurer Heppenstall Richard was granted 89,286 shares (SEC Form 4)](https://www.quantisnow.com/insight/cfo-treasurer-heppenstall-richard-was-granted-89286-shares-sec-form-6731088)
- 2026-09-30 23:36 UTC [SEC Form 3] [SEC Form 3 filed by new insider Heppenstall Richard](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-heppenstall-richard-6731087)
- 2026-09-30 13:15 UTC [SEC Form 8-K] [Carlsmed Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/carlsmed-inc-filed-sec-form-8-k-leadership-update-regulation-fd-6730261)
- 2026-09-28 12:30 UTC [Leadership Update] [Carlsmed Appoints Richard Heppenstall as Chief Financial Officer](https://www.quantisnow.com/insight/carlsmed-appoints-richard-heppenstall-as-chief-financial-officer-6727244)
- 2026-09-15 23:00 UTC [Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical](https://www.quantisnow.com/insight/carlsmed-inc-files-patent-infringement-lawsuit-against-degen-medical-6716646)
- 2026-09-15 21:07 UTC [Insider Buy] [Amendment: Large owner Presidio Management Group Xii, L.L.C. bought $3,000,000 worth of shares (200,000 units at $15.00) (SEC Form 4)](https://www.quantisnow.com/insight/amendment-large-owner-presidio-management-group-xii-llc-bought-3000000-6716478)
- 2026-09-10 22:38 UTC [SEC Form 4] [SEC Form 4 filed by Chief Operating Officer Bertolini Jeffrey](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-operating-officer-bertolini-jeffrey-6712207)
- 2026-09-10 22:37 UTC [SEC Form 3] [New insider Bertolini Jeffrey claimed ownership of 22,489 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-bertolini-jeffrey-claimed-ownership-of-22489-shares-sec-6712205)
- 2026-09-08 20:06 UTC [SEC Form 8-K] [Carlsmed Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/carlsmed-inc-filed-sec-form-8-k-leadership-update-regulation-fd-6708246)
- 2026-09-08 20:05 UTC [Carlsmed, Inc. Announces Chief Operating Officer Appointment](https://www.quantisnow.com/insight/carlsmed-inc-announces-chief-operating-officer-appointment-6708201)
- 2026-08-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-carlsmed-inc-6691958)
- 2026-08-05 20:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-carlsmed-inc-6665323)
- 2026-08-05 20:05 UTC [SEC Form 8-K] [Carlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/carlsmed-inc-filed-sec-form-8-k-results-of-operations-and-6665053)
- 2026-08-05 20:01 UTC [Earnings Date] [Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance](https://www.quantisnow.com/insight/carlsmed-reports-second-quarter-2026-financial-results-and-raises-full-year-6664763)
- 2026-08-03 12:00 UTC [Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures](https://www.quantisnow.com/insight/carlsmed-announces-favorable-reimbursement-for-aprevo-lumbar-procedures-6658728)
- 2026-07-27 20:01 UTC [Conference Announcement] [Carlsmed, Inc. To Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/carlsmed-inc-to-participate-in-upcoming-investor-conferences-6649539)
- 2026-07-22 20:01 UTC [Earnings Date] [Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026](https://www.quantisnow.com/insight/carlsmed-inc-to-report-second-quarter-2026-financial-results-on-6645092)
- 2026-07-01 12:29 UTC [Analyst Coverage Initiated] [Needham initiated coverage on Carlsmed with a new price target](https://www.quantisnow.com/insight/needham-initiated-coverage-on-carlsmed-with-a-new-price-target-6622008)
- 2026-06-22 10:13 UTC [SEC Form 4] [Director Oboyle Kevin C was granted 13,698 shares, increasing direct ownership by 79% to 31,031 units (SEC Form 4)](https://www.quantisnow.com/insight/director-oboyle-kevin-c-was-granted-13698-shares-increasing-direct-6609853)
- 2026-06-22 10:11 UTC [SEC Form 4] [Director Sidow Kevin was granted 13,698 shares, increasing direct ownership by 23% to 73,264 units (SEC Form 4)](https://www.quantisnow.com/insight/director-sidow-kevin-was-granted-13698-shares-increasing-direct-ownership-6609851)
- 2026-06-22 10:01 UTC [SEC Form 4] [Director Young Philip M was granted 13,698 shares, increasing direct ownership by 79% to 31,031 units (SEC Form 4)](https://www.quantisnow.com/insight/director-young-philip-m-was-granted-13698-shares-increasing-direct-6609802)
- 2026-06-22 10:02 UTC [SEC Form 4] [Director Root Jonathan D was granted 13,698 shares, increasing direct ownership by 3% to 497,697 units (SEC Form 4)](https://www.quantisnow.com/insight/director-root-jonathan-d-was-granted-13698-shares-increasing-direct-6609801)
- 2026-06-03 20:05 UTC [SEC Form 8-K] [Carlsmed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/carlsmed-inc-filed-sec-form-8-k-submission-of-matters-to-6586691)
- 2026-05-05 20:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-carlsmed-inc-6532162)
- 2026-05-05 20:05 UTC [SEC Form 8-K] [Carlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/carlsmed-inc-filed-sec-form-8-k-results-of-operations-and-6531963)
- 2026-05-05 20:01 UTC [Earnings Date] [Carlsmed® Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/carlsmed-reports-first-quarter-2026-financial-results-6531728)
- 2026-04-28 20:01 UTC [Conference Announcement] [Carlsmed, Inc. To Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/carlsmed-inc-to-participate-in-upcoming-investor-conferences-6518362)
- 2026-04-22 12:35 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-carlsmed-inc-6509706)
- 2026-04-22 12:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Carlsmed Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-carlsmed-inc-6509695)
- 2026-04-14 12:00 UTC [Earnings Date] [Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026](https://www.quantisnow.com/insight/carlsmed-inc-to-report-first-quarter-2026-financial-results-on-6498732)
- 2026-04-01 20:01 UTC [Conference Announcement] [Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference](https://www.quantisnow.com/insight/carlsmed-inc-to-participate-in-the-25th-annual-needham-virtual-6481730)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CARL
- RSS and alerts for CARL: https://www.quantisnow.com/docs/rss-feeds.md